BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26683959)

  • 1. Prognostic Significance of Mucin Antigen MUC1 in Various Human Epithelial Cancers: A Meta-Analysis.
    Xu F; Liu F; Zhao H; An G; Feng G
    Medicine (Baltimore); 2015 Dec; 94(50):e2286. PubMed ID: 26683959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value and potential drug target of phosphatase and tensin homolog in breast cancer patients: A meta-analysis.
    Xu F; Zhang C; Cui J; Liu J; Li J; Jiang H
    Medicine (Baltimore); 2017 Sep; 96(36):e8000. PubMed ID: 28885360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and clinicopathological value of MUC1 expression in colorectal cancer: A meta-analysis.
    Li C; Liu T; Yin L; Zuo D; Lin Y; Wang L
    Medicine (Baltimore); 2019 Mar; 98(9):e14659. PubMed ID: 30817589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUC1 Immunohistochemical Expression as a Prognostic Factor in Gastric Cancer: Meta-Analysis.
    Wang XT; Kong FB; Mai W; Li L; Pang LM
    Dis Markers; 2016; 2016():9421571. PubMed ID: 27190429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression.
    Deng J; Wang L; Chen H; Li L; Ma Y; Ni J; Li Y
    Cancer Metastasis Rev; 2013 Dec; 32(3-4):535-51. PubMed ID: 23609751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression.
    Hou R; Jiang L; Liu D; Lin B; Hu Z; Gao J; Zhang D; Zhang S; Iwamori M
    Int J Mol Med; 2017 Aug; 40(2):293-302. PubMed ID: 28586014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoresistance is associated with MUC1 and Lewis y antigen expression in ovarian epithelial cancers.
    Zhang D; Gao J; Zhu L; Hu Z; Hou R; Liu S; Tan M; Liu J; Lin B
    Int J Mol Sci; 2013 May; 14(6):11024-33. PubMed ID: 23708102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC1 overexpression predicts worse survival in patients with non-small cell lung cancer: evidence from an updated meta-analysis.
    Huang X; Sun Q; Chen C; Zhang Y; Kang X; Zhang JY; Ma DW; Xia L; Xu L; Xu XY; Ren BH
    Oncotarget; 2017 Oct; 8(52):90315-90326. PubMed ID: 29163831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of mucin antigens (MUC1 and MUC16) as a prognostic factor for mucinous adenocarcinoma of the uterine cervix.
    Togami S; Nomoto M; Higashi M; Goto M; Yonezawa S; Tsuji T; Batra SK; Douchi T
    J Obstet Gynaecol Res; 2010 Jun; 36(3):588-97. PubMed ID: 20598042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined evaluation of mucin antigen and E-cadherin expression may help select patients with gastric cancer suitable for minimally invasive therapy.
    Tanaka M; Kitajima Y; Sato S; Miyazaki K
    Br J Surg; 2003 Jan; 90(1):95-101. PubMed ID: 12520583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
    Zhang B; Xie Z; Li B
    Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
    Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E
    Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas.
    Baldus SE; Zirbes TK; Engel S; Hanisch FG; Mönig SP; Lorenzen J; Glossmann J; Fromm S; Thiele J; Pichlmaier H; Dienes HP
    Int J Cancer; 1998 Apr; 79(2):133-8. PubMed ID: 9583726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of the diagnostic value of Wisteria floribunda agglutinin-sialylated mucin1 and the prognostic role of mucin1 in human cholangiocarcinoma.
    Tang Z; Yang Y; Wang X; Meng W; Li X
    BMJ Open; 2019 Jan; 9(1):e021693. PubMed ID: 30700476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptamer-based detection of epithelial tumor marker mucin 1 with quantum dot-based fluorescence readout.
    Cheng AK; Su H; Wang YA; Yu HZ
    Anal Chem; 2009 Aug; 81(15):6130-9. PubMed ID: 19572710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer.
    Duncan TJ; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG
    World J Surg Oncol; 2007 Mar; 5():31. PubMed ID: 17349047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC1 is upregulated in advanced prostate cancer and is an independent prognostic factor.
    Genitsch V; Zlobec I; Thalmann GN; Fleischmann A
    Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):242-7. PubMed ID: 27165976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis.
    Zhang J; Gu Y; Liu X; Rao X; Huang G; Ouyang Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32696952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of mucin MUC1 and MUC2 in colorectal carcinoma and their clinical significance].
    Huang WB; Shi LH; Zhu XQ; Xu GX; Qi Q
    Ai Zheng; 2002 Nov; 21(11):1231-4. PubMed ID: 12526222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients.
    Scholz C; Heublein S; Lenhard M; Friese K; Mayr D; Jeschke U
    BMC Res Notes; 2012 Oct; 5():551. PubMed ID: 23036050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.